Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/HCT vs Losartan/HCT in Mild-to-Moderate Hypertension
NCT00274638Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2002
- Primary completion
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telmisartan in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline in the last 6-hour mean diastolic blood pressure as measured by Ambulatory Blood Pressure Monitoring at 6 weeks. Started Jul 2002; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00274638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274638.